Pfizer (PFE.N) on Tuesday reported its first quarterly loss since 2019, as the U.S. drugmaker recorded $5.6 billion in charges related to its COVID products such as its antiviral treatment Paxlovid and vaccine Comirnaty.
Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease , is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang Rattay/Illustration/File Photoon Tuesday reported its first quarterly loss since 2019, as the U.S. drugmaker recorded $5.6 billion in charges related to its COVID products such as its antiviral treatment Paxlovid and vaccine Comirnaty.
Sales of the COVID-19 pill and the vaccine it makes with German partner BioNTech SE had boosted Pfizer's revenue to record levels in the last two years.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Chicago First Alert Weather: First snowfall of the season on HalloweenThe heaviest snow is forecast for parts of Northwest Indiana for Tuesday evening and Tuesday night.
Leer más »
Pfizer RSV vaccine lags GSK’s as head-to-head competition underwayPfizer (PFE.N), which dominated COVID vaccine sales, now finds itself looking up at GSK (GSK.L), whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead since the shots launched this summer.
Leer más »
Freeze Watch issued for two Northeast Ohio counties Monday night, Tuesday morningDigital content producer at News 5
Leer más »
Sixers Expect To Have James Harden At Practice On TuesdaySixers Expect To Have James Harden At Practice On Tuesday - RealGM Wiretap
Leer más »